Rivastigmine on its best behaviour in Alzheimer's disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1239, 2000-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine: A Review of its Use in Alzheimer's Disease

By Spencer C.M.   Noble S.  

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 391-411

Adis International

Access to resources Recommend Favorite

Review of rivastigmine and its clinical applications in Alzheimer’s disease and related disorders

By Desai A.   Grossberg G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimer’s Disease

By Lamb H.M.   Goa K.L.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 303-318

Adis International

Access to resources Recommend Favorite

Rivastigmine often underdosed in Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Rivastigmine transdermal patch: a guide to its use in dementia of the Alzheimer's type

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 4, 2008-04 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite